Mark J Levin's Net Worth

$1.33 Billion

Estimate Recalculated Mar 1, 2024 03:08PM EST

Who is Mark J Levin?

Mark J Levin has an estimated net worth of $1.33 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Blueprint Medicines Corp, Nurix Therapeutics, Inc., Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., Foundation Medicine, Inc., ZAFGEN, INC., Allena Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Eleven Biotherapeutics, Inc., CytomX Therapeutics, Inc., and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Mark J Levin's CIK is 0001180428

Past Insider Trading and Trends

2015 was Mark J Levin's most active year for acquiring shares with 28 total transactions. Mark J Levin's most active month to acquire stocks was the month of May. 2007 was Mark J Levin's most active year for disposing of shares, totalling 851 transactions. Mark J Levin's most active month to dispose stocks was the month of October. 2018 saw Mark J Levin paying a total of $4,079,104.60 for 12,379,669 shares, this is the most they've acquired in one year. In 2021 Mark J Levin cashed out on 21,434,231 shares for a total of $322,683,542.21, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.93

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-25.12%
-1.00M
2.98M
Scheduled
Aug 30
Form 4
+22,487.15%
3.96M
3.98M
Oct 10
Form 3
0
0
No matching records found

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.71%
51.03K
$1.55
$79,099.60
3.03M
Aug 22
Form 4
+26,895.94%
2.97M
$15.00
2.98M
Jul 23
Form 3
0
0
No matching records found

Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.15%
-1.00M
3.96M
Scheduled
Nov 10
Form 4
-16.77%
-1.00M
4.96M
Scheduled
Sep 22
Form 4
0
0
Jun 9
Form 4
0
0
Jun 11
Form 4
+1,986.77%
5.68M
$16.00
5.96M
Jul 22
Form 3
0
0
No matching records found

Revolution Medicines, Inc. (RVMD) Snapshot price: $29.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-543.11K
$30.21
-$16,406,962.48
0
Jun 3 - Jun 4
Form 4
-71.55%
-1.37M
$30.57
-$41,764,208.12
543.11K
May 25 - May 26
Form 4
-21.36%
-1.50M
5.52M
Feb 24
Form 4
-12.46%
-1.00M
7.02M
Dec 2
Form 4
-11.08%
-1.00M
8.02M
Sep 9
Form 4
+2,560.14%
10.52M
10.93M
Feb 18
Form 3
0
0
No matching records found

PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16.06

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,750.00%
7.69M
7.97M
Jun 5
Form 3
0
0
No matching records found